Although her research interests run the gamut from cell and molecular biology to nanotechnology and biomedical engineering, one organ attracts the bulk of Sangeeta Bhatia?s attention: the liver. Her ...

President Christina Paxson P’19 and Sangeeta Bhatia ’90 P’25 commemorated 130 years since women joined Brown’s campus and 120 years since women of color joined campus in an event hosted by the Brown ...

This story is part of our "This Moment In Cancer" series. Three MIT professors are innovating at the tiniest possible scale — developing tools to see, target and kill cancer cells before they can ...

On July 28, 2009, Sangeeta Bhatia answered viewer questions about artificial organs, balancing a career with motherhood, and more. Please note we are no longer accepting questions, but see The Many ...

The biomedical engineer behind the human microliver and a urine test for cancer detection, Sangeeta Bhatia, has received the $500,000 Lemelson-MIT Prize for mid-career inventors. Bhatia is a Howard ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Glympse Bio, Inc. announced today that it has raised $22 million in Series A funding. The proceeds of this round will be devoted to conducting clinical trials for ...

Receive emails about upcoming NOVA programs and related content, as well as featured reporting about current events through a science lens. Sangeeta Bhatia: There is a whole new field of re-growing ...

A polymath trained in medicine and engineering, Bhatia made her name working at the intersection of nanomaterials and disease detection and treatment — in the process forming five companies. Now she’s ...

Bioengineering researchers at the University of California, San Diego have invented a process to help turn embryonic stem cells into the types of specialized cells being sought as possible treatments ...

CAMBRIDGE, Mass. -- Our DNA is under constant siege from a variety of damaging agents. Damage to DNA and the ability of cells to repair that damage has broad health implications, from aging and ...

Researchers are hoping to use nanotechnology to develop more targeted treatments for drug-resistant bugs. Antibiotic resistance is a growing problem, especially among a type of bacteria that are ...

Satellite Bio, a Cambridge startup focused on developing tissue implants to “repair, restore, or even replace” diseased or dying organs, launched Wednesday with $110 million in funding. The company, ...